Bulevirtide monotherapy for 48 weeks in patients with HDV-related compensated cirrhosis and clinically significant portal hypertension
Elisabetta Degasperi, Maria Paola Anolli, Sara Uceda Renteria, Dana Sambarino, Marta Borghi, Riccardo Perbellini, Caroline Scholtès, F. Facchetti, Alessandro Loglio, Sara Monico, Mirella Fraquelli, Andrea Costantino, Ferruccio Ceriotti, Fabien Zoulim, Pietro Lampertico
Topics & Concepts
MedicineCirrhosisGastroenterologyInternal medicinePortal hypertensionHBsAgAlanine aminotransferaseLiver functionChronic hepatitisHepatitis B virusVirusImmunologyHepatitis B Virus StudiesLiver Disease and TransplantationHepatitis C virus research